Edarbyclor comprises a combination of two medications, azilsartan medoxomil, and chlorthalidone, which collaboratively address hypertension, also known as high blood pressure.
Hypertension, a chronic condition, results from elevated pressure within the blood vessels. While individuals with hypertension typically do not experience noticeable symptoms, the condition can lead to enduring harm. Over time, increased pressure can cause tears in the blood vessels that, upon healing, may give rise to obstructions and blood clots.